News / Events

EVERSANA Sponsors the Rare Diseases and Orphan Products Breakthrough Summit

Improving the lives of people with rare diseases.
The National Organization for Rare Disorders (NORD®), an independent nonprofit, is leading the fight to improve the lives of rare disease patients and families. NORD is committed to accelerating research, raising awareness, providing valuable information and driving public policy that benefits the millions of Americans impacted by rare diseases.

As fierce allies to the rare community, EVERSANA is sponsoring NORD’s annual summit in Washington, D.C. from October 21-22. Meet with us at Booth #206 during exhibition hours.

On Tuesday, October 22 at 3:10 pm EST, Bhaskar Sambasivan, President of Patient Services and Chief Strategy Officer, will present his session, “Ahead of Its Time: Next-Generation Technology and Innovation in Rare Diseases.” He will provide valuable insight into how technology is advancing rare disease diagnosis, research and treatment.

For the 400 million people affected by rare disease, EVERSANA is on a mission to advance life sciences for a healthier world. Together with our clients, we aim to create better patient experiences, break down the barriers to access, and bring safe and effective therapies to patients around the world.

Click here to learn about our patient-centered solutions such as clinical trial recruitment platforms, patient engagement & communication, access & affordability solutions, and adherence & nursing support.

EVERSANA Sponsors Global Genes’ RARE Patient Advocacy Summit

As the largest gathering of rare disease patients, caregivers, thought leaders and other rare disease stakeholders in the world, the RARE Patient Advocacy Summit is an unparalleled opportunity to forge meaningful connections with other rare advocates and take home actionable strategies and tools to accelerate change. Summit Experience: • A jam-packed, two-day program filled with […]

Connect with EVERSANA at CBI’s Outcomes-Based Agreements & Innovative Payer Contracting

EVERSANA is attending the CBI’s Outcomes-Based Agreements & Innovative Payer Contracting in Philadelphia, PA from October 2-3. EVERSANA Managing Consultant, Robert Blank, will present his session “Value Based Contracts – Operational Challenges and Best Practices” on Wednesday, October 2 at 4:30 pm. Blank recently wrote a white paper titled, “Pharmaceutical Contracting from Volume to Value” […]

Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines

PALO ALTO, Calif. And CHICAGO – September 10, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, and EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced a partnership to advance the industry standard by which digital medicines will be ordered, dispensed, and covered by […]

EVERSANA is a Proud Sponsor of Cell & Gene Meeting on the Mesa

EVERSANA is a proud sponsor of Cell & Gene Meeting on the Mesa, one of the foremost conferences known for bringing together industry leaders to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to […]

EVERSANA Proudly Sponsors The 5th Annual CAR-TCR Summit

EVERSANA is a proud sponsor and panelist of the 5th annual CAR-TCR Summit this September 11-13 in Boston, Massachusetts. The summit brings together more than 1000 global leaders dedicated to innovating, developing and delivering CAR and TCR cell-based immunotherapies to patients across pharma, biotech, regulatory bodies, academia, and solution/service providers. EVERSANA’s General Manager Seth Gordon […]

Visit EVERSANA at the National Association of Specialty Pharmacy (NASP)

Meet our team of experts at the NASP Annual Meeting & Expo in Washington, D.C. September 9 – 12, 2019. EVERSANA BOOTH #914 Tuesday, September 10 7:00 am – 8:00 pm Wednesday, September 11 6:00 am – 2:30 pm Disruptive Therapies Call for a Disruptive Business Model Scientific breakthroughs in regenerative therapies are disrupting the […]

EVERSANA Sponsors EPP’s 9th Life Sciences Pricing Forum

EPP’s 9th Life Sciences Pricing Forum is taking place in Munich, Germany on October 14-16. EVERSANA is particularly pleased to be partnering with the EPP this year as we tackle critical topics for Global Pricing such as: Pricing in a complex eco-system Pricing for new therapies such as digital and regenerative Dealing with pricing transparency […]

EVERSANA Sponsors Medicaid Drug Rebate Program Summit

Join us at the 2019 Medicaid Drug Rebate Program Summit, September 23-25 in Chicago, Illinois! The summit provides unparalleled access to the government regulators creating the rules, the industry leaders interpreting them, and the pharmaceutical executives implementing them. This year, join us for these sessions: PRESENTATION: Where Can a GP Person Add More Value With […]

EVERSANA Sponsors World Drug Safety Congress Europe 2019

Terrapinn’s World Drug Safety Congress Europe, September 10-11 in Amsterdam, focuses on how to drive pharmacovigilance operations forward, better drug safety capabilities, technological functions and risk management measures. We help you make the best drug safety decisions, so that you can protect your brand and improve your patient’s outcomes. Here are some of our solutions […]